Literature DB >> 25074681

Kidney and liver transplantation in children with fibrocystic liver-kidney disease: data from the US Scientific Registry of Transplant Recipients: 1990-2010.

Jessica W Wen1, Susan L Furth, Rebecca L Ruebner.   

Abstract

The natural history and survival of children with fibrocystic liver-kidney disease undergoing solid organ transplantation have infrequently been described. We report outcomes in a cohort of US children with fibrocystic liver-kidney disease receiving solid organ transplants over 20 yr. Retrospective cohort study of pediatric transplant recipients with diagnoses of fibrocystic liver-kidney disease from 1/1990 to 3/2010, using data from the SRTR. Subjects were categorized by the first transplanted organ: LT, KT, or SLK. Primary outcomes were death, re-transplant, transplant of the alternate organ, or initiation of dialysis. Seven hundred and sixteen subjects were transplanted in this period. Median age at first transplant was 9.7 yr. Of the LT, 14 (19%) required a second liver transplant at median of 0.2 yr, and five (7%) required kidney transplant or dialysis at a median of 9.0 yr. Of the KT, 188 (31%) required a second kidney transplant or dialysis at a median of 5.9 yr. Twenty-nine (5%) subsequently received liver transplant at a median of 6.0 yr. Among patients in this registry, far more children underwent kidney than liver transplants. The risk of subsequently needing transplantation of an alternate organ was low.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Caroli's syndrome; autosomal recessive polycystic kidney; congenital hepatic fibrosis; kidney transplantation; liver fibrocystic disease; liver transplantation; pediatric

Mesh:

Year:  2014        PMID: 25074681     DOI: 10.1111/petr.12330

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  4 in total

Review 1.  ADPKD: clinical issues before and after renal transplantation.

Authors:  Piergiorgio Messa; Carlo Maria Alfieri; Emanuele Montanari; Mariano Ferraresso; Roberta Cerutti
Journal:  J Nephrol       Date:  2016-10-20       Impact factor: 3.902

Review 2.  Fibrocystic liver disease: novel concepts and translational perspectives.

Authors:  Alberto Lasagni; Massimiliano Cadamuro; Giovanni Morana; Luca Fabris; Mario Strazzabosco
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

Review 3.  Diagnosis and Management of Hepatobiliary Complications in Autosomal Recessive Polycystic Kidney Disease.

Authors:  Andrew Wehrman; Alyssa Kriegermeier; Jessica Wen
Journal:  Front Pediatr       Date:  2017-05-29       Impact factor: 3.418

4.  An Empirical Biomarker-Based Calculator for Cystic Index in a Model of Autosomal Recessive Polycystic Kidney Disease-The Nieto-Narayan Formula.

Authors:  Jake A Nieto; Michael A Yamin; Itzhak D Goldberg; Prakash Narayan
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.